SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000728083-12-000003
Filing Date
2012-02-06
Accepted
2012-02-06 15:45:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 orexigen.txt SC 13G 7556
  Complete submission text file 0000728083-12-000003.txt   9023
Mailing Address 437 MADISON AVE NEW YORK NY 10022
Business Address 437 MADISON AVE NEW YORK NY 10022 2127563300
FIRST MANHATTAN CO (Filed by) CIK: 0000728083 (see all company filings)

IRS No.: 131957714 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Subject) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-83422 | Film No.: 12573494
SIC: 2834 Pharmaceutical Preparations